Office Based Pediatric Urologic Procedures: A Safe and Effective Alternative to Interventions Under Anesthesia.


Journal

Urology
ISSN: 1527-9995
Titre abrégé: Urology
Pays: United States
ID NLM: 0366151

Informations de publication

Date de publication:
08 2022
Historique:
received: 25 01 2022
revised: 04 04 2022
accepted: 10 04 2022
pubmed: 25 4 2022
medline: 3 8 2022
entrez: 24 4 2022
Statut: ppublish

Résumé

To report on our experience performing office-based pediatric urologic procedures. We hypothesize that office-based interventions are safe and effective for children, avoiding unnecessary risk and cost associated with general anesthesia. We retrospectively identified patients undergoing office-based interventions from 2014 to 2019, including lysis of penile or labial adhesions, division of skin bridges, meatotomy and excision of benign lesion. Success was defined as a completed attempt in the office. Failure includes any unsuccessful office attempts. Complications include 30-day ED visits/readmissions and recurrent skin bridge post division of skin bridge. We identified 1326 interventions: 491 lyses of penile adhesions (37%), 320 division of skin bridges (24%), 128 lyses of labial adhesions (10%), 348 meatotomies (26%), and 39 excisions of benign lesions (3%) [Table 1]. There was a >95% success rate reported in every procedure with an overall complication rate of 0.6%. Excision of benign lesion had 100% success rate. ED visits within 30 days are rare (0.2%), and no patients required admission after their procedure [Table 2]. The rate of recurrence was highest following lysis of labial adhesions (13.3%). Of the 54 patients who underwent retreatment, very few required general anesthesia (n = 6). Office-based urologic interventions in children are well tolerated with excellent safety and efficacy. Complications and recurrence are universally low. Ultimately, 99.5% of this cohort was managed under local anesthetics, thereby avoiding the risks of anesthesia use in the pediatric population.

Identifiants

pubmed: 35461916
pii: S0090-4295(22)00309-0
doi: 10.1016/j.urology.2022.04.008
pii:
doi:

Substances chimiques

Anesthetics, Local 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

223-226

Informations de copyright

Copyright © 2022 Elsevier Inc. All rights reserved.

Auteurs

Aznive Aghababian (A)

Division of Urology, Children's Hospital of Philadelphia, Philadelphia, PA.

Sameer Mittal (S)

Division of Urology, Children's Hospital of Philadelphia, Philadelphia, PA; Division of Urology, Perelman Center for Advanced Care, Hospital of the University of Pennsylvania, Philadelphia, PA.

Sahar Eftekharzadeh (S)

Division of Urology, Children's Hospital of Philadelphia, Philadelphia, PA.

Dawud Hamdan (D)

Division of Urology, Children's Hospital of Philadelphia, Philadelphia, PA.

John Weaver (J)

Division of Urology, Children's Hospital of Philadelphia, Philadelphia, PA.

Karl Godlewski (K)

Division of Urology, Children's Hospital of Philadelphia, Philadelphia, PA.

Katherine Fischer (K)

Division of Urology, Children's Hospital of Philadelphia, Philadelphia, PA.

Christopher Long (C)

Division of Urology, Children's Hospital of Philadelphia, Philadelphia, PA; Division of Urology, Perelman Center for Advanced Care, Hospital of the University of Pennsylvania, Philadelphia, PA.

Dana Weiss (D)

Division of Urology, Children's Hospital of Philadelphia, Philadelphia, PA; Division of Urology, Perelman Center for Advanced Care, Hospital of the University of Pennsylvania, Philadelphia, PA.

Jason Van Batavia (J)

Division of Urology, Children's Hospital of Philadelphia, Philadelphia, PA; Division of Urology, Perelman Center for Advanced Care, Hospital of the University of Pennsylvania, Philadelphia, PA.

Mark Zaontz (M)

Division of Urology, Children's Hospital of Philadelphia, Philadelphia, PA; Division of Urology, Perelman Center for Advanced Care, Hospital of the University of Pennsylvania, Philadelphia, PA.

Stephen Zderic (S)

Division of Urology, Children's Hospital of Philadelphia, Philadelphia, PA; Division of Urology, Perelman Center for Advanced Care, Hospital of the University of Pennsylvania, Philadelphia, PA.

Thomas Kolon (T)

Division of Urology, Children's Hospital of Philadelphia, Philadelphia, PA; Division of Urology, Perelman Center for Advanced Care, Hospital of the University of Pennsylvania, Philadelphia, PA.

Douglas Canning (D)

Division of Urology, Children's Hospital of Philadelphia, Philadelphia, PA; Division of Urology, Perelman Center for Advanced Care, Hospital of the University of Pennsylvania, Philadelphia, PA.

Aseem Shukla (A)

Division of Urology, Children's Hospital of Philadelphia, Philadelphia, PA; Division of Urology, Perelman Center for Advanced Care, Hospital of the University of Pennsylvania, Philadelphia, PA.

Arun Srinivasan (A)

Division of Urology, Children's Hospital of Philadelphia, Philadelphia, PA; Division of Urology, Perelman Center for Advanced Care, Hospital of the University of Pennsylvania, Philadelphia, PA. Electronic address: srinivasana3@email.chop.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH